Use of topical steroids is largely restricted by irrational emotional concerns in both patients and physicians

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 11, 2008, Pages 1560-1561

  Zuberbier, T ^a   Maurer, M ^b   Augustin, M ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Allergic rhinitis; Atopic dermatitis; Corticosteroids

Indexed keywords

CORTICOSTEROID DERIVATIVE;

ALLERGIC RHINITIS; ARTICLE; ATOPIC DERMATITIS; DRUG USE; EMOTION; GERMANY; HEALTH SURVEY; HUMAN; ONLINE SYSTEM; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADRENAL CORTEX HORMONES; EMOTIONS; HUMANS; HYPERSENSITIVITY; PATIENTS; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC;

EID: 53749086444     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01866.x     Document Type: Article

References (2)

1. Zuberbier T, Orlaw S, Paller AS, Taïeb A, Allen R, Hernanz-Hermosa JM et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 2006 118 : 226 232.
2. Maurer M, Zuberbier T. Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire study. Allergy 2007 62 : 1057 1063.